Analysis | Samples | Factors | Units |
---|---|---|---|
ESI/QTOF negative ion mode | S00012694 | Drug combination:Isoproterenol | 13C-label position in pyruvate:C1 | Peak area |
ESI/QTOF negative ion mode | S00012695 | Drug combination:Isoproterenol | 13C-label position in pyruvate:C2 | Peak area |
ESI/QTOF negative ion mode | S00012692 | Drug combination:Isoproterenol + Leelamine | 13C-label position in pyruvate:C1 | Peak area |
ESI/QTOF negative ion mode | S00012693 | Drug combination:Isoproterenol + Leelamine | 13C-label position in pyruvate:C2 | Peak area |
ESI/QTOF negative ion mode | S00012688 | Drug combination:None | 13C-label position in pyruvate:C1 | Peak area |
ESI/QTOF negative ion mode | S00012689 | Drug combination:None | 13C-label position in pyruvate:C2 | Peak area |
ESI/QTOF negative ion mode | S00012696 | Drug combination:Rosiglitazone | 13C-label position in pyruvate:C1 | Peak area |
ESI/QTOF negative ion mode | S00012697 | Drug combination:Rosiglitazone | 13C-label position in pyruvate:C2 | Peak area |
ESI/QTOF negative ion mode | S00012690 | Drug combination:Rosiglitazone + Leelamine | 13C-label position in pyruvate:C1 | Peak area |
ESI/QTOF negative ion mode | S00012691 | Drug combination:Rosiglitazone + Leelamine | 13C-label position in pyruvate:C2 | Peak area |